NASDAQ:AZTA

Azenta (AZTA) Stock Forecast, Price & News

$45.02

-0.96 (-2.09%)

(As of 02:27 PM ET)

Compare

Today's Range: $44.86
▼
$46.27
50-Day Range: $36.45
▼
$46.12
52-Week Range: $36.01
▼
$78.14

Volume: 386,472 shs
Average Volume: 1.11 million shs
Market Capitalization: $2.93 billion

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $64.20

Azenta MarketRank™ Forecast

Analyst Rating: Moderate Buy
2.75 Rating Score
Upside/Downside: 42.1% Upside
$64.20 Price Target
Short Interest: Healthy
9.36% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: 1.07
Based on 3 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: 300.00%
From $0.15 to $0.60 Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.37 out of 5 stars

Medical Sector

149th out of 981 stocks

Special Industry Machinery, Not Elsewhere Classified Industry

3rd out of 14 stocks

3.4

Analyst's Opinion

Consensus Rating
Azenta has received a consensus rating of Buy. The company's average rating score is 2.75, and is based on 3 buy ratings, 1 hold rating, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $64.20, Azenta has a forecasted upside of 42.1% from its current price of $45.19.
Amount of Analyst Coverage
Azenta has only been the subject of 1 research reports in the past 90 days.

3.0

Short Interest

Percentage of Shares Shorted
9.36% of the float of Azenta has been sold short.
Short Interest Ratio / Days to Cover
Azenta has a short interest ratio ("days to cover") of 5.
Change versus previous month
Short interest in Azenta has recently decreased by 15.42%, indicating that investor sentiment is improving significantly.

0.0

Dividend Strength

Dividend Yield
Azenta does not currently pay a dividend.
Dividend Growth
Azenta does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for AZTA.

2.8

News and Social Media Coverage

News Sentiment
Azenta has a news sentiment score of 1.07. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.51 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 3 news articles for Azenta this week, compared to 3 articles on an average week.
Search Interest
7 people have searched for AZTA on MarketBeat in the last 30 days.

1.7

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Azenta insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 1.67% of the stock of Azenta is held by insiders.
Percentage Held by Institutions
96.42% of the stock of Azenta is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

1.9

Earnings and Valuation

Earnings Growth
Earnings for Azenta are expected to grow by 300.00% in the coming year, from $0.15 to $0.60 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Azenta is -71.73, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Azenta is -71.73, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Azenta has a P/B Ratio of 1.01. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Azenta (NASDAQ:AZTA) Stock

Azenta, Inc. provides life science sample exploration and management solutions for the life sciences market in North America, Europe, China, the Asia Pacific, and internationally. The company operates through two reportable segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated cold sample management systems for compound and biological sample storage; equipment for sample preparation and handling; consumables; and instruments that help customers in managing samples throughout their research discovery and development workflows. The Life Sciences Services segment provides comprehensive sample management programs, integrated cold chain solutions, informatics, and sample-based laboratory services to advance scientific research and support drug development. This segment's services include sample storage, genomic sequencing, gene synthesis, laboratory processing, laboratory analysis, biospecimen procurement, and other support services. It serves a range of life science customers, including pharmaceutical companies, biotechnology companies, biorepositories, and research institutes. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Burlington, Massachusetts.

Receive AZTA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Azenta and its competitors with MarketBeat's FREE daily newsletter.

AZTA Stock News Headlines

June 6, 2023 | finance.yahoo.com

Azenta Insiders Added US$752k Of Stock To Their Holdings

May 31, 2023 | markets.businessinsider.com

Vazyme Signs Global Strategic Cooperation Agreement with Azenta

June 8, 2023 | Edge On The Street (Ad)

New "Mined in America" Lithium Opportunities?

The average electric vehicle needs 138 pounds of lithium carbonate for its battery components. But China currently controls the entire lithium supply chain.

May 25, 2023 | finance.yahoo.com

Azenta (AZTA) Declined on Weak Management Guidance

May 24, 2023 | finance.yahoo.com

Azenta Announces Collaboration with the Lupus Research Alliance to Support the Advancement of Lupus Research and Drug Discovery

May 20, 2023 | americanbankingnews.com

Azenta, Inc. (NASDAQ:AZTA) Receives Average Rating of "Moderate Buy" from Analysts

May 17, 2023 | finance.yahoo.com

Azenta to Participate in the 23rd Annual B. Riley Securities Institutional Investor Conference

May 14, 2023 | americanbankingnews.com

KeyCorp Comments on Azenta, Inc.'s Q3 2023 Earnings (NASDAQ:AZTA)

June 8, 2023 | Edge On The Street (Ad)

New "Mined in America" Lithium Opportunities?

The average electric vehicle needs 138 pounds of lithium carbonate for its battery components. But China currently controls the entire lithium supply chain.

May 12, 2023 | msn.com

Azenta hits 52-week low after Q2 miss

May 12, 2023 | americanbankingnews.com

Azenta (NASDAQ:AZTA) Hits New 1-Year Low After Earnings Miss

May 11, 2023 | finance.yahoo.com

What Does The Future Hold For Azenta, Inc. (NASDAQ:AZTA)? These Analysts Have Been Cutting Their Estimates

May 11, 2023 | americanbankingnews.com

Azenta (NASDAQ:AZTA) Price Target Lowered to $55.00 at Needham & Company LLC

May 10, 2023 | markets.businessinsider.com

Analyst Ratings for Azenta

May 10, 2023 | americanbankingnews.com

Azenta (NASDAQ:AZTA) Issues Q3 Earnings Guidance

May 9, 2023 | finance.yahoo.com

Azenta Reports Results of Second Quarter of Fiscal 2023 and Announces Business Realignment

May 8, 2023 | benzinga.com

Azenta's Earnings Outlook

May 8, 2023 | americanbankingnews.com

Azenta (AZTA) to Release Quarterly Earnings on Tuesday

May 8, 2023 | americanbankingnews.com

Reviewing Azenta (NASDAQ:AZTA) and Sumitomo Heavy Industries (OTCMKTS:SOHVY)

May 3, 2023 | finance.yahoo.com

Azenta Announces Fiscal 2023 Second Quarter Earnings Conference Call and Webcast

April 28, 2023 | finance.yahoo.com

Here’s Why Polen Capital Sold Azenta (AZTA)

April 28, 2023 | americanbankingnews.com

Short Interest in Azenta, Inc. (NASDAQ:AZTA) Rises By 53.8%

April 25, 2023 | americanbankingnews.com

Azenta, Inc. (NASDAQ:AZTA) Given Consensus Rating of "Moderate Buy" by Brokerages

April 22, 2023 | americanbankingnews.com

Azenta (NASDAQ:AZTA) Earns "Buy" Rating from Needham & Company LLC

April 19, 2023 | msn.com

Needham Maintains Azenta (AZTA) Buy Recommendation

April 13, 2023 | finance.yahoo.com

Azenta to Participate in the 22nd Annual Needham Virtual Healthcare Conference

April 10, 2023 | forbes.com

Recent Employment Data Could Mean Some Respite From Rising Interest Rates For Investors - Forbes AI Newsletter April 8th

See More Headlines

AZTA Price History

30 days | 90 days | 365 days | Advanced Chart

AZTA Company Calendar

Last Earnings: 5/09/2023
Today: 6/08/2023
Next Earnings (Estimated): 8/08/2023
Fiscal Year End: 9/30/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Special industry machinery, not elsewhere classified
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:AZTA
CUSIP: N/A
CIK: 933974
Web: www.brooks.com
Phone: (978) 262-2400
Fax: 978-262-2500
Employees: 3,100
Year Founded: N/A

Price Target and Rating

Average Stock Price Forecast: $64.20
High Stock Price Forecast: $70.00
Low Stock Price Forecast: $55.00
Forecasted Upside/Downside: +42.1%
Consensus Rating: Moderate Buy
Rating Score (0-4): 2.75
Research Coverage: 4 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($0.63)
Trailing P/E Ratio: N/A
Forward P/E Ratio: 301.27
P/E Growth: N/A
Net Income: $2.13 billion
Net Margins: -7.79%
Pretax Margin: -4.06%
Return on Equity: 0.81%
Return on Assets: 0.72%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 7.46
Quick Ratio: 6.75

Sales & Book Value

Annual Sales: $555.50 million
Price / Sales: 5.30
Cash Flow: $1.21 per share
Price / Cash Flow: 37.27
Book Value: $44.83 per share
Price / Book: 1.01

Miscellaneous

Outstanding Shares: 65,170,000
Free Float: 64,079,000
Market Cap: $2.95 billion
Optionable: Optionable
Beta: 1.56

Key Executives

Dr. Stephen S. Schwartz (Age 64)
CEO, Pres & Director
Comp: $1.17M

Mr. Lindon G. Robertson (Age 61)
Exec. VP & CFO
Comp: $1M

Ms. Vandana Sriram (Age 49)
Sr. VP of Global Fin., Corp. Controller & Principal Accounting Officer
Comp: $800.2k

Mr. Jason W. Joseph (Age 52)
Sr. VP, Gen. Counsel & Corp. Sec.
Comp: $651.75k

Mr. Michael Paulo
VP and Chief Information & Digital Officer

Sara Silverman
Head of Investor Relations & Corp. Communications

Mr. John E. O'Brien (Age 53)
Sr. VP of Corp. Devel.

Dr. Claribel Purcell
Sr. VP of Global Sales

Mr. J. Robert Woodward
Sr. VP of Global Quality & Regulatory

Mr. David C. Gray Ph.D. (Age 57)
Sr. VP and Chief Strategy & New Bus. Officer

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

AZTA Stock - Frequently Asked Questions

Should I buy or sell Azenta stock right now?: 4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Azenta in the last twelve months. There are currently 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" AZTA shares.
View AZTA analyst ratings or view top-rated stocks.
What is Azenta's stock price forecast for 2023?: 4 Wall Street analysts have issued 1 year target prices for Azenta's stock. Their AZTA share price forecasts range from $55.00 to $70.00. On average, they anticipate the company's share price to reach $64.20 in the next twelve months. This suggests a possible upside of 42.1% from the stock's current price.
View analysts price targets for AZTA or view top-rated stocks among Wall Street analysts.
How have AZTA shares performed in 2023?: Azenta's stock was trading at $58.22 at the beginning of 2023. Since then, AZTA stock has decreased by 22.4% and is now trading at $45.19.
View the best growth stocks for 2023 here.
Are investors shorting Azenta?: Azenta saw a decrease in short interest in the month of May. As of May 15th, there was short interest totaling 5,980,000 shares, a decrease of 15.4% from the April 30th total of 7,070,000 shares. Based on an average daily trading volume, of 1,200,000 shares, the short-interest ratio is presently 5.0 days. Currently, 9.4% of the shares of the stock are short sold.
View Azenta's Short Interest.
When is Azenta's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Tuesday, August 8th 2023.
View our AZTA earnings forecast.
How were Azenta's earnings last quarter?: Azenta, Inc. (NASDAQ:AZTA) released its earnings results on Tuesday, May, 9th. The company reported ($0.06) earnings per share for the quarter, missing the consensus estimate of ($0.04) by $0.02. The company earned $148.40 million during the quarter, compared to analysts' expectations of $161.90 million. Azenta had a negative net margin of 7.79% and a positive trailing twelve-month return on equity of 0.81%. The company's quarterly revenue was up 2.0% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.12 earnings per share.
What ETFs hold Azenta's stock?: ETFs with the largest weight of Azenta (NASDAQ:AZTA) stock in their portfolio include ROBO Global Robotics & Automation ETF (ROBO), Harbor Health Care ETF (MEDI), ROBO Global Healthcare Technology and Innovation ETF (HTEC), BlackRock Future Innovators ETF (BFTR), Syntax Stratified MidCap ETF (SMDY), Invesco S&P MidCap Quality ETF (XMHQ), Invesco Nasdaq Future Gen 200 ETF (QQQS) and Pacer Lunt MidCap Multi-Factor Alternator ETF (PAMC).

What guidance has Azenta issued on next quarter's earnings?: Azenta issued an update on its third quarter earnings guidance on Tuesday, May, 9th. The company provided earnings per share (EPS) guidance of ($0.07)-$0.03 for the period, compared to the consensus earnings per share estimate of $0.06. The company issued revenue guidance of $150-$168 million, compared to the consensus revenue estimate of $170.72 million.
What is Azenta's stock symbol?: Azenta trades on the NASDAQ under the ticker symbol "AZTA."
Who are Azenta's major shareholders?: Azenta's stock is owned by a variety of retail and institutional investors. Top institutional investors include BlackRock Inc. (9.81%), Kayne Anderson Rudnick Investment Management LLC (6.46%), JPMorgan Chase & Co. (4.63%), Allspring Global Investments Holdings LLC (3.43%), State Street Corp (3.03%) and Brown Advisory Inc. (2.60%). Insiders that own company stock include Jesus Linda De, Kimberly Crowley, Lindon G Robertson and Matthew Mcmanus.
View institutional ownership trends.
How do I buy shares of Azenta?: Shares of AZTA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Azenta's stock price today?: One share of AZTA stock can currently be purchased for approximately $45.19.
How much money does Azenta make?: Azenta (NASDAQ:AZTA) has a market capitalization of $2.95 billion and generates $555.50 million in revenue each year. The company earns $2.13 billion in net income (profit) each year or ($0.63) on an earnings per share basis.
How many employees does Azenta have?: The company employs 3,100 workers across the globe.
How can I contact Azenta?: Azenta's mailing address is 15 Elizabeth Dr, Chelmsford, Massachusetts 01824-4111. The official website for the company is www.brooks.com. The company can be reached via phone at (978) 262-2400, via email at investor@brooks.com, or via fax at 978-262-2500.

This page (NASDAQ:AZTA) was last updated on 6/8/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial